Covered recipient · General Payments record
DANIEL T MILTON
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$248,646.08
- Reported across 318 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,665.00 | 8 |
| Travel and Lodging | $6,740.55 | 10 |
| Food and Beverage | $1,306.87 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $21,636.81 | 18 |
| PFIZER INC. | $14,434.39 | 10 |
| Amgen Inc. | $136.65 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.09 | 3 |
| Janssen Biotech, Inc. | $41.91 | 1 |
| GENZYME CORPORATION | $41.16 | 1 |
| ABBVIE INC. | $36.51 | 2 |
| Tempus AI, Inc | $35.54 | 2 |
| Octapharma USA, Inc. | $27.92 | 1 |
| Daiichi Sankyo Inc. | $27.77 | 1 |
| Merck Sharp & Dohme Corporation | $25.31 | 1 |
| PharmaEssentia USA Corporation | $23.32 | 1 |
| Blueprint Medicines Corporation | $23.28 | 1 |
| Verity Pharmaceuticals Inc. | $22.21 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.79 | 1 |
| BeiGene USA, Inc. | $19.33 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.34 | 1 |
| Genentech USA, Inc. | $18.06 | 1 |
| Deciphera Pharmaceuticals Inc. | $16.70 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.41 | 1 |
| GlaxoSmithKline, LLC. | $14.33 | 1 |
| Gilead Sciences, Inc. | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.